To this end, we have evidence that Hrk is under epigenetic control in the GBM cell lines we used, as we observed marked  Hrk upregulation in response the DNMT1 inhibitor, 5-azacytidine in all cell lines (Supplementary Figure 4). This evidence concerns the gene DNMT1 and glioblastoma.